Professional Documents
Culture Documents
Controlled Document
EMEA Business Continuity Plan – COVID 19
DOCUMENT INFORMATION
DOCUMENT DISTRIBUTION
01 Document Control
03
04
05
06
REVISION STATUS
TABLE OF CONTENT
Contents
1. INTRODUCTION .................................................................................................................................4
1.1 COMMON SIGNS OF INFECTION .................................................................................................................4
2. PURPOSE ...........................................................................................................................................4
3. SCOPE ................................................................................................................................................5
4. REFERENCES, FORMS, FILES & DOCUMENTS .............................................................................5
5. DEFINITIONS, ACRONYMS AND ABBREVIATIONS ........................................................................5
6. BUSINESS CONTINUITY PREPAREDNESS ....................................................................................6
6.1 Risk Assessment .................................................................................................................................................6
6.2 General Prevention and Mitigation Measures .....................................................................................................7
6.3 Strategic Preparedness and Emergency Response by Departments & Business Units .......................................8
6.3.1 SENIOR MANAGEMENT TEAM (SMT) ........................................................................................................8
6.3.2 IT & COMMUNICATION .................................................................................................................................8
6.3.3 HUMAN RESOURCES (HR) ............................................................................................................................ 8
6.3.4 FINANCE ........................................................................................................................................................... 9
6.3.5 HSE.....................................................................................................................................................................9
6.3.6 SUPPLY CHAIN ................................................................................................................................................9
6.3.7 OPERATIONS & PROJECTS ......................................................................................................................... 10
6.3.7.1. GUIDELINES FOR COUNTRY SPECIFIC PLANS ............................................................................. 10
6.4 Privacy .............................................................................................................................................................. 11
7. ATTACHMENTS............................................................................................................................... 11
1. INTRODUCTION
Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common
cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-
CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a
new strain that has not been previously identified in humans.
Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed
investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV
from dromedary camels to humans. Several known coronaviruses are circulating in animals that
have not yet infected humans.
COVID-19 is the infectious disease caused by the most recently discovered coronavirus. This
new virus and disease were unknown before the outbreak began in Wuhan, China, in December
2019.
On 30 January 2020, WHO announced that the COVID-19 outbreak was a Public Health
Emergency of International Concern.
There is currently no vaccine to prevent coronavirus disease 2019 (COVID-19). The best way to
prevent illness is to avoid being exposed to this virus. However, as a reminder, Enerflex
recommends everyday preventive actions to help prevent the spread of respiratory diseases,
including viruses such as; cold, flu and COVID-19.
People can catch COVID-19 from others who have the virus. The disease can spread from
person to person through small droplets from the nose or mouth which are spread when a person
with COVID-19 coughs or exhales. These droplets land on objects and surfaces around the
person. Other people then catch COVID-19 by touching these objects or surfaces, then touching
their eyes, nose or mouth.
People can also catch COVID-19 if they breathe in droplets from a person with COVID-19 who
coughs out or exhales droplets.
2. PURPOSE
This document is developed to provide guidelines to the EMEA business leaders and employees
for taking preventive measures on immediate basis and to prepare the respective teams to act
under more critical situation to ensure business continuity, health and safety of EMEA employees
and its customers during outbreak of Corona Virus (COVID-19) till situations becomes normal.
3. SCOPE
This procedure is applicable to all Enerflex employees, suppliers, sub-contractors at all Enerflex
office and sites in EMEA.
For all standard company abbreviations see EFX-MEA-PJ-A-001 Users Guide to Definitions,
Abbreviations and Acronyms.
CoV Coronaviruses
COVID-19 Corona Virus Disease 2019
EFX Enerflex
HSE Health Safety and Environment
MOH Ministry of Health
nCoV Novel Coronavirus
WHO World Health Organization
Hazards and Effects Management Process (HEMP) conducted for COVID-19, four scenarios
are identified, each scenario has Prevention and Mitigation Controls identified, refer to
Attachment-1 for details.
Table-1
Scenario Description
Below are the basic preventive measures to be followed by all EFX EMEA employees:
• Maintain at least 1-meter (3 feet) distance between yourself and anyone who is coughing
or sneezing.
• Avoid touching eyes, nose and mouth. (avoid touching your face)
• Make sure you, and the people around you, follow good respiratory hygiene
• *Stay home if you feel unwell. If you have a fever, cough and difficulty breathing, seek
medical attention. Follow the directions of your local health authority and inform your
supervisor.
(* If you are at site immediately report to site clinic or the nearest hospital as applicable)
Below are the specific preventive measures taken on all EFX operated offices and sites:
• Any team member who has infected (COVID-19) family member or closed relative must
report this to his/her manager and to HSE.
• Any employee has symptoms of illness to stay home until getting better and free of fever
and other symptoms, consult doctor for further advise and inform your manager.
• HR & HSE has right to ask employee to perform medical test & checkups as necessary.
• If someone results +VE COVID-19 then follow the hospital and health authorities’
directions, including recommendation of getting family members, teammates, friends and
other’s details who were in physical contact with him.
• Inform your manager before your personal vacation trip is planned, manager shall
collaborate with HSE for correct advise and measures.
The following actions are defined as minimum requirements by the below mentioned department
under all listed scenarios in table-1 to support business continuity in regional offices and at
project sites.
EMEA Senior Management Team (SMT) shall take proactive measures in advance to
develop, review and update Site Specific Business Continuity Plans and provide necessary
support to regional teams.
SMT shall ensure that employee backup plans are in place and communicated
appropriately.
• Communicate to employees
6.3.4 FINANCE
6.3.5 HSE
• Prepare education materials for employees on health risk and good hygiene.
(including minimizing physical contact).
• Request employees who had direct contact with effected employee to work
remotely to the extent possible until asymptomatic (min 14 days) in collaboration
with HR.
• Review material contents (customers and suppliers) to assess risk to supply chain
and projects in the event of business interruption & recommend mitigation steps.
o In case our field personnel are reduced, we would delay none critical
maintenance activities to focus on maintaining the compressors
operational.
o Staff are willing to extend their rotations in the event of travel delays,
quarantines etc.
Country Specific Contingency Plans are developed within EFX EMEA Operations, refer to
specific country plan for complete details;
• When not, on-site personnel are encouraged to stay at their designated desks /
offices and to avoid contact as much as possible.
6.4 PRIVACY
7. ATTACHMENTS
Review
resource plan
to provide
coverage- site
specific backup
plan.
LIKELIHOOD
PERSONNEL CORPORATE PROPERTY ENVIRONMENTAL REPUTATION
CONSEQUENCE IMPACT IMPACT IMPACT IMPACT IMPACT A B C D E
Rare Unlikely Possible Likely Almost Certain
Lost Time
No threat to the effective operation, Damage Changes to existing soil and/or water quality in the
Injury/ Widespread complaints and 3A 3B 3C 3D 3E
3 Severe
Temporary
but exposes Enerflex MEA to repair/replacement cost up affected area, with local changes to bio-diversity, but no
anger 3 Severe
unacceptable consequences to $50,001 to $100,000 loss of ecological or land-use function. LOW MODERATE SIGNIFICANT HIGH EXTREME
partial disability
No significant impact,
dealt with internally by Damage Changes to existing soil and/or water quality in the 2A 2B 2C 2D 2E
MTI/ Restricted work Limited complaints with
2 Serious
injury management repair/replacement cost up affected area, but no changes to bio-diversity or ecological
local impact 2 Serious
to $5,001 to $50,000 or land-use function. LOW LOW MODERATE SIGNIFICANT HIGH
A B C D E
RISK MANAGEMENT ACTION Rare Unlikely Possible Likely Almost Certain
Unacceptable risk. Activity not to proceed until we can modify the threat, frequency or consequence to reduce risk class to Moderate, Low or As
EXTREME Low as Reasonably Practicable (ALARP). Has happened in the Has happened at the
Has happened more
Never heard of in the Heard of in the Organization or more location or more than
Likelihood than once per year at
industry industry than once per year in once per year in the
the location
HIGH Modify the threat, frequency or consequences to reduce the risk class to Moderate, Low or As Low as Reasonably Practicable (ALARP). the Industry Organization
Note: All foreseeable events with the Risk Rating as Extreme or Severity Level 5 as Per Enerflex Risk Assessment Matrix will be considered Major Accident Hazards (MAH).
EFX-MEA-QES-A-005 Rev. 00 Date 24-03-2019 Page 1 of 1